Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure

scientific article published on 18 December 2017

Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/EJHF.1101
P698PubMed publication ID29251807

P50authorFaiez ZannadQ19631268
Nilesh SamaniQ19665717
Rudolf Allert de BoerQ21546679
Piotr PonikowskiQ22114836
Stefan D. AnkerQ30310195
Aeilko H ZwindermanQ87492860
Hans L HillegeQ91827926
Paulene A QuinnQ114321856
Marco MetraQ39274051
Chim C. LangQ41297830
Kenneth DicksteinQ43248428
Leong L NgQ61120317
Thong Huy CaoQ61139674
Gerasimos FilippatosQ63107352
Dirk J van VeldhuisenQ82060328
P2093author name stringJohn G Cleland
Simon P R Romaine
Donald J L Jones
Adrian A Voors
Daniel C S Chan
Johanna Elisabeth Emmens
P2860cites workThe risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysisQ26801304
Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisitionQ30800087
PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancementsQ31145457
Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeabilityQ33542396
Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failureQ34504604
Serum amyloid A in uremic HDL promotes inflammationQ35917487
Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure PatientsQ36052803
Relations of lipid concentrations to heart failure incidence: the Framingham Heart StudyQ36693904
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptideQ37102996
Filamins in cell signaling, transcription and organ developmentQ37671360
Structure of HDL: particle subclasses and molecular components.Q38293426
Therapeutic potential of HDL in cardioprotection and tissue repairQ38293492
Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failureQ38896366
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failureQ40313672
Impaired High-Density Lipoprotein Anti-Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure.Q40651491
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.Q40777024
Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patientsQ43178283
High-density lipoprotein cholesterol levels and prognosis in advanced heart failureQ43283941
Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteinsQ46079103
High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failureQ47980523
Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failureQ48160505
Serum fetuin-A levels in patients with systolic heart failure.Q48568569
Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteinsQ59566873
Exercise Training in Patients with Chronic Heart Failure Promotes Restoration of High-Density Lipoprotein Functional PropertiesQ59566888
Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failureQ74420350
Lung epithelium-specific proteins: characteristics and potential applications as markersQ77932822
Deficiency of filamin A in endothelial cells impairs left ventricular remodelling after myocardial infarctionQ85854243
P577publication date2017-12-18
P1433published inEuropean Journal of Heart FailureQ5017954
P1476titleProteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure

Reverse relations

cites work (P2860)
Q91137527Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets
Q87935386Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
Q87935310Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL? Reply
Q91917022Structure-function relationships of HDL in diabetes and coronary heart disease

Search more.